Oncobit enables personalized cancer care by developing highly sensitive diagnostic and monitoring tests, to find the best cancer treatment for each patient. We are addressing the rapidly expanding market of precision oncology and personalized disease monitoring using non-invasive technologies. We perform the complex bioinformatic analysis and data interpretation, and provide results and therapy-decision support in personalized reports that are tailored to the physicians’ and patients’ needs. We are based in Zurich and our founding team consists of professionals with deep expertise in oncology, bioinformatics, software development, and management.
Oncobit on LinkedIn
Hear from Claudia, our CEO: Oncobit in a nutshell
Contact us if you want to learn more about Oncobit. We are looking forward to hearing from you!
February ’21 – Oncobit attends prestigious Innosuisse Market Validation Camp
January ’21 – Oncobits wins CHF 10’000 at the first stage of Venture Kick and
makes it under the Top 60 of the De Vigier Award
November ’20 – Oncobit receives USZ Health Innovation Hub support
October ’20 – Oncobit ranks in the Top-5 of the Swiss AI Award